Proteolytic Mechanisms, Not Malnutrition, Cause Loss of Muscle Mass in Kidney Failure

作者: William E. Mitch

DOI: 10.1053/J.JRN.2006.04.014

关键词:

摘要: Hypoalbuminemia and muscle atrophy are frequently found in patients with chronic kidney disease (CKD) being treated by dialysis. These abnormalities usually attributed to malnutrition, meaning that they caused an inadequate diet. However, the evidence indicates malnutrition is rarely mechanism causing loss of protein stores. Instead, low values serum albumin closely related presence inflammation mass attributable activation specific proteases. In uremic rodents patients, initial step caspase-3. This cleaves complex structure muscle, its action can be detected a characteristic 14-kDa actin fragment insoluble fraction muscle. The second uremia-induced ubiquitin-proteasome system, which rapidly degrades proteins released caspase-3 cleavage proteins. Activation both system occur when there suppression cellular signaling pathway activated insulin/insulinlike growth factor 1, phosphatidylinositol 3-kinase/Akt pathway. A potential therapeutic target for preventing stimulate activity this

参考文章(37)
J Bergström, E Löfberg, J Wernerman, B Anderstam, Correction of acidosis in dialysis patients increases branched-chain and total essential amino acid levels in muscle. Clinical Nephrology. ,vol. 48, pp. 230- 237 ,(1997)
M. N. Goodman, Tumor necrosis factor induces skeletal muscle protein breakdown in rats American Journal of Physiology-endocrinology and Metabolism. ,vol. 260, ,(1991) , 10.1152/AJPENDO.1991.260.5.E727
William E. Mitch, James L. Bailey, Xiaonan Wang, Claudine Jurkovitz, David Newby, S. Russ Price, Evaluation of signals activating ubiquitin-proteasome proteolysis in a model of muscle wasting American Journal of Physiology-cell Physiology. ,vol. 276, ,(1999) , 10.1152/AJPCELL.1999.276.5.C1132
D. Reaich, S. M. Channon, C. M. Scrimgeour, S. E. Daley, R. Wilkinson, T. H. Goodship, Correction of acidosis in humans with CRF decreases protein degradation and amino acid oxidation American Journal of Physiology-endocrinology and Metabolism. ,vol. 265, ,(1993) , 10.1152/AJPENDO.1993.265.2.E230
D. Reaich, T. H. J. Goodship, S. M. Channon, K. A. Graham, S. Downie, Correction of acidosis in hemodialysis decreases whole-body protein degradation. Journal of The American Society of Nephrology. ,vol. 8, pp. 632- 637 ,(1997) , 10.1681/ASN.V84632
Trevor N. Stitt, Doreen Drujan, Brian A. Clarke, Frank Panaro, Yekatarina Timofeyva, William O. Kline, Michael Gonzalez, George D. Yancopoulos, David J. Glass, The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Molecular Cell. ,vol. 14, pp. 395- 403 ,(2004) , 10.1016/S1097-2765(04)00211-4
Brian J.G. Pereira, Leland Shapiro, Andrew J. King, Matheos E. Falagas, James A. Strom, Charles A. Dinarello, Plasma levels of IL-1β, TNFα and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients Kidney International. ,vol. 45, pp. 890- 896 ,(1994) , 10.1038/KI.1994.117
Deanna K. Levenhagen, T. Alp Ikizler, Paul J. Flakoll, Lara B. Pupim, John R. Brouillette, Raymond M. Hakim, Intradialytic parenteral nutrition improves protein and energy homeostasis in chronic hemodialysis patients Journal of Clinical Investigation. ,vol. 110, pp. 483- 492 ,(2002) , 10.1172/JCI15449
Andreas Festa, Ralph D’Agostino, George Howard, Leena Mykkänen, Russell P. Tracy, Steven M. Haffner, Chronic Subclinical Inflammation as Part of the Insulin Resistance Syndrome The Insulin Resistance Atherosclerosis Study (IRAS) Circulation. ,vol. 102, pp. 42- 47 ,(2000) , 10.1161/01.CIR.102.1.42